reference/29503710

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/29503710

Outgoing Links

Predicate	Object
contentType	Journal Article\|Research Support, Non-U.S. Gov't
issn	1471-2407
issueIdentifier	1
pageRange	203-
publicationName	BMC Cancer
startingPage	203
bibliographicCitation	Keam B, Im SA, Kim HJ, Oh DY, Kim JH, Lee SH, Chie EK, Han W, Kim DW, Moon WK, Kim TY, Park IA, Noh DY, Heo DS, Ha SW, Bang YJ. Prognostic impact of clinicopathologic parameters in stage II/III breast cancer treated with neoadjuvant docetaxel and doxorubicin chemotherapy: paradoxical features of the triple negative breast cancer. BMC Cancer. 2007 Nov 01;7():203. PMID: 17976237; PMCID: PMC2217558.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-9219-3350 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0003-2027-7472 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_468d416003fbc9bd2e024f8a6e1b89a4 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_dce68b61044e581129b4e52f14a01e6b http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_2153c88db5da839197449f42e2b3dee4 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d39351cc6782ecb659ccd0b06ffc01af http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_dc5ec49e3e3e1156ca481cf5592805c7 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f3f2cd76bcd147aa52c0447393dc8493 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_8fa507fe957fd3f77d76ab8ce5395efa http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_5afe11089fe1a36156fe1817e6cc6b98 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_3a85b60a54c4a619dcc9fd2f0039aa01 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_6b115037f7a31497832bee3269459454 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_bdc894c4e7fc938881b030d71c6ed6ab http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_8d98f5b4132c92bbad239589139a7ed0 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b70a60c31f8f73cd19eda094faddaa76 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_65b4915fc977f76d2f9754caf41b7a00 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_0a2673b1af101b30c47f2d09e613a012 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_58b8568d18eb465cec02d76659b2a216
date	2007-11-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://doi.org/10.1186/1471-2407-7-203 https://pubmed.ncbi.nlm.nih.gov/PMC2217558 https://pubmed.ncbi.nlm.nih.gov/17976237
isPartOf	http://rdf.ncbi.nlm.nih.gov/pubchem/journal/22020 https://portal.issn.org/resource/ISSN/1471-2407
language	English
source	https://scigraph.springernature.com/ https://pubmed.ncbi.nlm.nih.gov/ https://www.crossref.org/
title	Prognostic impact of clinicopathologic parameters in stage II/III breast cancer treated with neoadjuvant docetaxel and doxorubicin chemotherapy: paradoxical features of the triple negative breast cancer
discusses	http://id.nlm.nih.gov/mesh/M0001483 http://id.nlm.nih.gov/mesh/M0023752 http://id.nlm.nih.gov/mesh/M0184558 http://id.nlm.nih.gov/mesh/M0443608 http://id.nlm.nih.gov/mesh/M0014578 http://id.nlm.nih.gov/mesh/M0006784
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_52a517e173e6fa70285ded085be0d86f http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_e1afa113b0d884f36154ce9339375de8 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_f1b2452da84551fc91db93425b6a20d9 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID148124 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_43830973f74de180729ad1e755d592ad http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID11451 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID31703 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_4f3366af2ce1555e259faab86aad3bef http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7102

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129159660 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128482492 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129138006 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127952853 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127676247

Total number of triples: 56.